Amended Statement of Beneficial Ownership (3/a)
January 06 2021 - 4:38PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Cambre Jerome |
2. Date of Event Requiring Statement (MM/DD/YYYY)
12/31/2020
|
3. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [VMD]
|
(Last)
(First)
(Middle)
625 E. KALISTE SALOOM RD. |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) Vice President of Sales / |
(Street)
LAFAYETTE, LA 70508
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY) 12/31/2020
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Phantom Share Units (1) | (2) | 5/9/2021 | Common Shares | 14621.0 | $0.0 (3) | D | |
Phantom Share Units (1) | (4) | 5/9/2022 | Common Shares | 2274.0 | $0.0 (3) | D | |
Phantom Share Units (1) | (5) | 5/9/2023 | Common Shares | 2772.0 | $0.0 (3) | D | |
Explanation of Responses: |
(1) | The original Form 3 filed on December 31, 2020 is being amended by this Form 3/A solely to include Phantom Share Units held by the reporting person that were unintentionally omitted. |
(2) | Represents an award granted in 2018 under the Issuer's Phantom Share Unit Plan which vests on May 9, 2021, subject to the Reporting Person's continued employment with the Issuer on such vesting date. |
(3) | Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common stock which will be determined based on the Issuer's share price on the vesting date. |
(4) | Represents an award granted in 2019 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2021 and May 9, 2022, subject to the Reporting Person's continued employment with the Issuer on such vesting date. |
(5) | Represents an award granted in 2020 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2021, May 9, 2022, and May 9, 2023, subject to the Reporting Person's continued employment with the Issuer on such vesting date. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Cambre Jerome 625 E. KALISTE SALOOM RD. LAFAYETTE, LA 70508 |
|
| Vice President of Sales |
|
Signatures
|
/s/ Jerome Cambre | | 1/6/2021 |
**Signature of Reporting Person | Date |
VieMed Healthcare (NASDAQ:VMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
VieMed Healthcare (NASDAQ:VMD)
Historical Stock Chart
From Sep 2023 to Sep 2024